Genomic landscape of hormone therapy-resistant HR-positive, HER2-negative breast cancer. Chaubal R, Talker E, Chitra J, Kadam R, et al. Breast Cancer Res Treat 2025 Jul 12. doi: 10.1007/s10549-025-07759.

Read + Share

Amedeo Smart

Independent Medical Education

Chaubal R, Talker E, Chitra J, Kadam R, et al. Genomic landscape of hormone therapy-resistant HR-positive, HER2-negative breast cancer. Breast Cancer Res Treat 2025 Jul 12. doi: 10.1007/s10549-025-07759.
PMID: 40652157